Executives at a major opioid company, Insys Therapeutics, were found guilty by a federal jury on Thursday for, among other misdeeds, bribing doctors to prescribe their fentanyl-based painkiller — in another sign that the federal government and the public are increasingly ready to hold individuals and companies responsible for their role in the nationwide opioid epidemic.
Throughout the trial, prosecutors detailed Insys’s far-reaching efforts to sell as much of its potent opioid painkiller, Subsys, as possible, beyond its approved use for cancer pain. According to the New York Times, prosecutors accused the company of paying off doctors — for, say, fake educational talks — so they would prescribe the drug widely.
For details: https://bit.ly/2UYhH3r